Corcept Therapeutics Announces Fourth Quarter, Full-Year 2020 Preliminary Selected Financial Results and 2021 Revenue Guidance; Provides Corporate Update
Go back to Corcept Therapeutics Announces Fourth Quarter, Full-Year 2020 Preliminary Selected Financial Results and 2021 Revenue Guidance; Provides Corporate Update| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 113.98 +2.36 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $111.62 | 52 Week High | $10.00 | |||
| Open | $108.87 | 52 Week Low | $3.22 | |||
| Day High | $115.28 | P/E | N/A | |||
| Day Low | $108.25 | EPS | $-0.46 | |||
| Volume | 1,021,065 | |||||
